SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

A sharp move in VKTX has fueled speculation about a possible Novo Nordisk partnership or other buyout interest, alongside talk of heavy call activity and short covering; no deal is confirmed, and many traders dismiss the rumors as a pump. The discussion also centers on upcoming VK2735 presentations and the longer-term Phase 3 program, with skeptics pointing to the wait for pivotal data and recent volatile trading.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs abrupt departure as CEO has put succession and China-related export scrutiny at the center of the discussion. Traders debate whether leadership uncertainty and possible sales restrictions threaten Nvidias outlook or whether its AI-chip business can withstand the change; talk of Huang returning or a successor being chosen remains speculative.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisks stronger-than-expected quarterly results and raised outlook, driven by demand for oral Wegovy, have fueled hopes of a recovery. Traders remain divided over whether pill growth can offset diabetes weakness, pricing pressure and competition from Eli Lilly.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

The CHMP reaffirmed its negative opinion on Zevras European marketing application for arimoclomol (Miplyffa), prompting a sharp selloff; the European Commissions final decision remains pending. Traders debate whether the reaction is overdone, with bulls emphasizing the drugs existing U.S. business and cash position while bears focus on the lost European opportunity and management concerns.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

A quarterly revenue miss and lack of forward guidance have fueled a sharp selloff and concerns about cash runway, dilution, and management communication. Bullish traders point to Anktivas bladder-cancer expansion and positive BCG-nave trial results, while looking to the London conferences for clarity on the filing timeline and commercial outlook; the newly authorized sepsis trial is another speculative growth theme.

Cisco Systems, Inc. engages in the design, manufacture, and sale of Internet Protocol-based networking products and services related to the communications and information technology industry. The firm operates through the following geographical segments: the Americas, EMEA, and APJC. Its products include the following categories: Secure, Agile Networks, Internet for the Future, Collaboration, End-to-End Security, Optimized Application Experiences, and Other Products. The company was founded by Sandra Lerner and Leonard Bosack in 1984 and is headquartered in San Jose, CA.

Cisco Systems, Inc.

Ciscos earnings beat and raised outlook have been overshadowed by a selloff focused on lower gross margins, slower product-order growth, and a softer sequential revenue outlook. Bulls see strong AI-networking demand and solid results as a buying opportunity, while skeptics question growth durability and valuation.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels planned BLA filing for its prostate cancer candidate has been pushed from late 2026 to mid-2027 amid FDA discussions and assay refinement, driving a sharp selloff. Traders debate whether this is a manageable CMC delay that leaves the clinical data intact or a sign of execution and management-trust problems, with added concern about possible dilution; some are buying the dip while others expect a longer period of uncertainty.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs steep pullback followed a rapid rally fueled by speculation that it could gain from Nvidias leadership turmoil. Traders disagree on whether the drop is profit-taking after an overheated run or part of broader weakness in AI and semiconductor stocks, with concerns about valuations and AI spending competing against optimism about AMDs potential market-share gains.

Autonomi (ANT) is a cryptocurrency launched in 2025and operates on the Arbitrum platform. Autonomi has a current supply of 1,200,000,000 with 346,331,579 in circulation. The last known price of Autonomi is 0.0311505 USD and is down -0.06 over the last 24 hours. It is currently trading on 15 active market(s) with $124,825.83 traded over the last 24 hours. More information can be found at https://autonomi.com.

Aragon

Much of the attention appears to come from ticker confusion: traders are using $ANT.X to discuss Anthropics planned IPO, debating its valuation and potential impact on AI stocks and market liquidity. Aragon-related posts separately mention the projects dissolution and completed token redemption, with some holders asking what that means for their tokens.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arms shares are under pressure after its earnings beat failed to offset concern about softer-than-hoped royalty growth and limited upside in its outlook, amid a broader semiconductor selloff. Traders are split between viewing the AI and data-center opportunity as supportive and questioning whether growth justifies the stocks valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PEP a suit alleges the gatorade no artificial flavors claim is misleading, per open class actions. lawsuit stage, nothing to claim. seems like flavor claims get read closely in court

StockTwits Web

PepsiCo Inc

 a suit alleges the gatorade no artificial flavors claim is misleading, per open class actions. lawsuit stage, nothing to claim. seems like flavor claims get read closely in court